because of its potent activity in vitro , efficacy in experimental tuberculosis and activity against drug resistant mycobacteria , amikacin merits further study as a potential therapeutic agent for tuberculosis and other mycobacterial infections .
C0002499
amikacin
C0026918
mycobacterial infections